NeuroFlow Secures $20M for Tech-Enabled Behavioral Health Integration Platform

NeuroFlow Secures $20M for Tech-Enabled Behavioral Health Integration Platform

What You Should Know:

– NeuroFlow raises $20M to expand its technology-enabled behavioral
health integration platform, led by Magellan Health.

– NeuroFlow’s suite of HIPAA-compliant, cloud-based tools
simplify remote patient monitoring, enable risk stratification, and facilitate
collaborative care. With NeuroFlow, health care organizations can finally
bridge the gap between mental and physical health in order to improve outcomes
and reduce the cost of care.


NeuroFlow, a Philadelphia-based digital health startup supporting technology-enabled behavioral health integration (tBHI), announces today the initial closing of a $20M Series B financing round led by Magellan Health, in addition to a syndicate including previous investors. Magellan is a leader in managing the fastest growing, most complex areas of health, including behavioral health, complete pharmacy benefits and other specialty areas of healthcare. 

NeuroFlow for Digital Behavioral Health Integration

NeuroFlow works with leading health plans, provider systems,
as well as the U.S. military and government to enhance virtual health programs
by delivering a comprehensive approach to whole-person care through digital
behavioral health integration – an evidence-based model to identify and treat
consumers with depression, anxiety and other behavioral health conditions
across all care settings.

Key features of the behavioral health platform include:

– Interoperability: Seamless EHR and system integrations minimize administrative burden and optimize current IT investments.

– Measurement-based Care & Clinical Decision Support: NeuroFlow enables MBC at scale, keeps the patient in the center of care, and continuously monitors for a consistent connection to critical data and clinical decision support.

– Performance Management & Reporting: Recognize
the impact of your BHI program, monitoring the impact of clinical interventions
on quality and cost of care while recognizing outliers requiring program
adjustments.

– Consumer Engagement & Self-Care: personalized
experience that encourages, rewards and recognizes continuous engagement and
monitoring

Maximize Efficiency, Revenue and Reimbursements

By integrating behavioral health into the primary care setting, increasing screening and self-care plans – NeuroFlow’s BHI solution can reduce ED utilization by 23% and inpatient visits by 10%. 80% of NeuroFlow users self-reported a reduction in depression or anxiety symptoms and 62% of users with severe depression score improve to moderate or better.

Telehealth Adoption Underscores Need for Behavioral
Healthcare

With record growth in telehealth adoption and historic spikes in depression and anxiety due to the ongoing pandemic, workflow augmentation solutions and the delivery of effective behavioral health care have been identified as top priorities in the industry. NeuroFlow’s technology increases access to personalized, collaborative care while empowering primary care providers, care managers, and other specialists to most effectively support patient populations by accounting for and addressing behavioral health. 

“Behavioral health is not independent of our overall health — it affects our physical health and vice versa, yet most underlying behavioral health conditions go unidentified or are ineffectively treated. Most healthcare providers are overburdened, so introducing the concept to account for a person’s mental health in addition to their primary specialty can be overwhelming and lead to inconsistent and inadequate treatment,” said NeuroFlow CEO Chris Molaro. “Technology, when used strategically, can enhance and augment providers, making the concept of holistic and value-based care feasible at scale and easy to implement.”

Strategic Partnership with Magellan

Magellan Health’s network of more than 118,000 credentialed
providers and health professionals are now poised to join NeuroFlow customers
across the country by leveraging the best-in-class integrated data and
analytics platform to meet the rising demand for enhanced mental health
services and support. By partnering with and investing in NeuroFlow, Magellan
has the opportunity to drive further adoption of NeuroFlow’s behavioral health
integration tools and drive collaborative care initiatives with its customers
as well as its vast network of credentialed providers and health professionals
across the country.

Expansion Plans

NeuroFlow will use the Series B proceeds to scale its
operations and support its growth in data analytics, artificial intelligence,
and direct health record integrations. NeuroFlow’s contracted user base has
grown 10x to over 330,000 in support of almost 200 commercial health systems,
payers, accountable care organizations, independent medical groups, and federal
agencies to provide technology-enabled care solutions.


Centene to bolster behavioral health services with $2.2B Magellan Health acquisition

The insurer will pay $95 per share in cash to acquire Magellan Health, a company providing an array of services, including pharmacy benefit management and behavioral health and employee assistance program services. The companies aim to develop a behavioral health platform.

Provider Pilot Uses Video Games as Therapy for Children with Autism

Provider Pilot Uses Video Games as Therapy for Children with Autism

What You Should Know:

– Magellan Health launches a pilot program for a group of
providers that will begin using video games as therapy for children with autism
and other behavioral health conditions. 

– As part of the pilot program, patients will be given
access to the video platform developed by Mightier, a digital health company
born out of Boston Children’s’ Hospital and Harvard. 

– The games include a wearable heart rate monitor &
tablet loaded with 25 different games, each designed to help children learn how
to regulate their emotional reactions and manage stress, anxiety through deep
breathing, etc.


Magellan Health,
Inc.,
one of the nation’s leaders in behavioral health, today
announced a collaboration between Magellan Healthcare (Magellan), the
behavioral and specialty healthcare segment of the company, and Neuromotion,
Inc., developer of Mightier, an
in-home digital platform that empowers children to learn lifelong emotional
skills through play, to make Mightier available to certain Magellan members in
a pilot program.

“Children are increasingly being diagnosed with behavioral
health disorders and the impact is felt by the entire family,” said Matthew
Miller, senior vice president, behavioral health, Magellan Healthcare. “We are
proud to launch this pilot with Mightier as a cost effective,
outcomes-based treatment. By teaching children how to navigate daily challenges
through visual technology they learn how to cope and properly manage their
stress in a meaningful and fun way.”

Pilot Program Details

Developed at Boston Children’s Hospital and Harvard Medical
School, the Mightier program pairs video games with clinically validated
emotion calming skills to help kids learn through play. In addition to the
video game platform, caregivers are supported with a personalized dashboard to
track progress, access to the Mightier Parent community, and 1-1 coaching with
a licensed, master’s level clinician to tailor the program to
their individual family needs.

Over the last three years, Mightier has reached more than
25,000 families worldwide, with thousands of new families being added every
month. Over 75 percent of families report improvement made possible by an
unwavering commitment to building an engaging experience supported by clinical
expertise.

By combining Magellan’s market-leading clinical experience and network of providers specializing in autism with Mightier’s innovative technology, children and families participating in the pilot will receive high-quality care focused on positive outcomes.

Jason Kahn, PhD, Mightier’s Chief Scientific Officer says the collaboration will set the stage to positively impact families and improve outcomes for children with ASD. “Mightier is a new tool that supports the increasing diagnoses of autism and other behavioral health disorders. Our solution meets kids and families where they are: at home. The pandemic amplifies this need even further, we need new ways to support kids and families. Our digital program can play a significant role by providing evidenced-based, personalized interventions from the comfort of home.”